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Commercial dialysate inhibits TNFa mRNA expression and NE-KB
DNA-binding activity in LPS-stimulated macrophages. Continuous am-
bulatory peritoneal dialysis is known to interfere with the normal inflam-
matory responses of macrophages in the peritoneal cavity. Commercial
peritoneal dialysis solution (CDS) has been shown to inhibit tumor
necrosis factor a (TNFa) release from LPS stimulated peritoneal macro-
phages. To further dissect the mechanism of this inhibition, we used
human blood-derived macrophages or the murine macrophage cell line,
P388D1, that were stimulated with LPS after pretreatment with CDS, and
tested TNFcr mRNA levels by Northern hybridization or reverse tran-
scriptase polymerase chain reaction. Time course studies demonstrated
that CDS lowered TNFa mRNA levels within 15 minutes of pretreatment
of cells. In addition, the CDS inhibited DNA binding activity of NF-gB
that is probably involved in regulation of LPS-mediated transcriptional
activation of the TNFa gene. Inhibition was dependent on both the low
pH and the lactate in the CDS, but was independent of the osmolarity or
glucose concentration. The rate of catabolism of TNFa mRNA was not
affected by CDS as demonstrated by actinomycin D chase experiments.
Thus, impairment of LPS-stimulated macrophage function by CDS is
associated with low TNFa mRNA which may be the result of the low
activity of NF-KB. Since NF-KB is involved in transcription regulation of a
large number of "early activation" genes, CDS may interfere with the
production of additional immunomodulatory proteins that are encoded by
genes possessing NF-KB site(s) in their promoter region.
Continuous ambulatory peritoneal dialysis (CAPD) has become
an important mode of treatment of end-stage kidney disease.
Unfortunately, in spite of recent advances and modifications of
the CAPD technique, the primary complication of this treatment
is still a high incidence of bacterial peritonitis [1, 2].
In an attempt to explain the frequency of this complication,
recent investigations were undertaken which showed that com-
mercially available peritoneal dialysis solution (CDS) has a detri-
mental effect on the host defense mechanism of the peritoneal
cavity [31. The predominant cell type in the dialysate of non-
infected peritoneal dialysis patients are peritoneal macrophages
(PM0) which function as the first line of defense against invading
pathogens [4]. The macrophage effector functions which include
phagocytosis and killing of microorganisms are greatly enhanced
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by pro-inflammatory cytokines, such as interleukin 1 (IL-i) and
tumor necrosis factor a (TNFa). These cytokines are produced by
activated macrophages and stimulate additional peritoneal resi-
dent cells. They also regulate the inflammatory processes that lead
to destruction and elimination of the pathogens. Therefore, PMØ
are vital to the eradication of bacterially originated peritonitis,
and their impaired biological function will have serious conse-
quences on the course of the peritonitis.
Commercial dialysis solution is a non-physiologic solution with
a pH of 5.2, high osmolarity and lactate concentration. Several
studies have shown that CDS impairs in vitro functions of both
peripheral blood leukocytes and PMØ [3, 5—7]. Since cytokines
are important mediators of the immune response, studies were
designed to test whether CDS will affect cytokine production by
PMØ. Among the cytokines produced and secreted by activated
macrophages are IL-i and TNFa, both of which regulate a variety
of inflammatory processes. Thus, treatment for one to two hours
with CDS was found to inhibit TNFa production by peripheral
blood mononuclear cells, which suggests impaired inflammatory
responses and increased susceptibility due to inhibition of TNFa-
mediated immune responses [5]. Since the pH of the peritoneal
fluid neutralizes within 15 to 30 minutes of CDS infusion into the
abdomen [6], we demonstrated that short 15 minute pretreatment
with CDS markedly suppressed the production and release of
TNFcs by activated PMØ. The inhibitory effect was attributed to
the low pH (5.2), and the high lactate concentration (40 mM) of
the CDS [7]. The purpose of the present study is to further
investigate the mechanism by which the CDS impairs PMØ
production of TNFa. We found that CDS inhibits TNFcw release
by macrophages at the level of gene transcription. To analyze
whether CDS can affect transcription regulation by DNA-binding
proteins that are up-regulated in activated macrophages, we
tested its effect on NF-KB DNA binding activity. Recent studies
have demonstrated that interaction of NF-KB with the TNFa
promoter may be essential for efficient LPS-mediated transcrip-
tional activation of the TNFa gene [8—10]. In addition, the
inhibitory effect of pyrrolidine dithiocarbamate on TNFa produc-
tion by monocytes was found to correlate with decreased TNFa
gene transcription and NF-KB activity [11]. We found that DNA
binding activity of NF-KB is inhibited by CDS, suggesting that
suppression of TNFa transcription is secondary to the effect of
CDS on the activity of transcription factors.
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Methods
Preparation of human peripheral blood-derived
macrophages (BDMØ)
Human peripheral blood was obtained from healthy donor
volunteers and maintained in sodium citrate solution. Buffy coats
were collected following centrifugation and mononuclear cells
were obtained by density gradient centrifugation on Histopaque
1077 (Sigma, St. Louis, MO, USA), according to Boyum [121.
Cells (2 X 106/mi) in complete RPMI 1640 medium [10% fetal
calf serum (FCS), 2 mrvi L-glutamine, 100 U/mi penicillin and 100
.tg/ml streptomycin all from Biological Industries, (Beth
Haemek, Israel) were cultured in 75 cm2 tissue culture flasks
(Bibby, Corning, NY, USA) at 50 X 106 cells/flask in an atmo-
sphere of 5% CO2 at 37°C. Monocytes were allowed to adhere for
90 minutes, followed by removal of non-adherent cells by exten-
sive washing. Flow cytometly analysis indicated that 85% of the
adherent cells expressed the macrophage/monocyte cell surface
marker, CD14. After 16 hours, adherent cells were detached from
the plastic using trypsin EDTA and seeded in six well plates (5 X
106 cells/well), in 3 ml of complete RPMI supplemented with 20%
pooled human AB serum instead of FCS, The cells were cultured
for ten days to allow them to differentiate into macrophages. At
this stage > 90% of the cells expressed CDI4 marker and
exhibited a macrophage-like morphology.
Cell lines
The murine macrophage-like cell line, P388D1, and the T cell
line, EL-4, were obtained from the American Tissue Culture
Collection (ATCC). All cells were maintained in complete RPMI.
Incubation of macrophages with CDS and LPS activation
BDMØ in six well plates, were preincubated with 3 ml of either
CDS (Dianeal© 1.5% glucose, Travenol Ltd., Ashdod, Israel) or
RPMI as a control, for varying time intervals as indicated. Cells
were then washed once with PBS, and supplemented with 3 ml of
RPMI containing 10 g/ml of E. coli 055: B5 lipopolysaccharide
(LPS) (Sigma) for additional two hours of incubation. P388D1
cells were treated according to a similar protocol using 50 ml
culture in 150 cm2 flasks. For the TNFa mRNA stability assay,
BDMØ were stimulated for two hours with LPS (10 .tg/ml), the
cells were washed once with PBS, exposed for 15 minutes to CDS
or medium, then replaced with fresh medium and incubated for
additional 30 minutes, after which actinomycin D was added
(1 ag/ml), and the cells were incubated for various lengths of time,
followed by RNA extraction. The actinomycin D treatment was
not toxic for the cells as assessed by measuring lactate dehydro-
genase (LDH) release.
To test the effect of CDS components and/or pH on macro-
phage functions, BDMØ or P388D1 cells were cultured as before
and treated with either the CDS Dianeal©, CDS containing 10
mM HEPES buffer, CDS without glucose, lactate, or both, or
possessing reduced glucose concentrations resulting in a lower
osmolarity, or RPMI as a control. Following 45 minutes of
incubation the cells were washed once with PBS and incubated in
the presence of LPS.
Northern blot analysis
RNA extraction. Total RNA was extracted from cells using
RNAzo1T° B (Biotecx Jab Inc., Houston, TX, USA) according to
the manufacturer's instructions. Following stimulation with LPS,
10 cells were harvested by trypsinization, washed once with PBS
and 2 ml of RNAzoV° B were added to the cell pellet. Cells were
lysed by five aspirations through a 21 G needle. Lysates were then
transferred to two eppendorf tubes supplemented with 100 d of
chloroform, vortexed for 15 seconds and incubated for five
minutes on ice. Tubes were then centrifuged for 30 minutes at 4°C
in a Microfuge E centrifuge (Beckman Instruments Inc., Palo
Alto, CA, USA), and the upper fraction (450 1.d) was transferred
to a new tube. RNA was precipitated by the addition of 450 .d of
isopropanol, a 45 minute incubation on ice, and 15 minutes of
centrifugation at 4°C. RNA pellets were washed with 70% etha-
nol, dried, resuspended in water, aliquoted to 15 .tg aiiquots with
0.3 M sodium acetate and 2.5 volumes of cold ethanol, and stored
in —70°C.
Gel electrophoresis, blotting and hybridization. Fifteen micro-
grams RNA from each sample were fractionated on 1.4% agarose
0,66 M formaldehyde gel and then transferred to a nylon mem-
brane (Hybond N+, Amersham Inc., Buckinghamshire, UK) [13].
Membranes were hybridized with random-primed [32PJ-labeled
probes [14] specific for TNFa [151 or J3-actin (16), (5 X i0
cpm/g, 1.5 to 2)< 106 cpm/ml) at 42°C with 50% formamide, 5 X
SSC (lx SSC is 0.15 M NaCI plus 0.015 M sodium citrate), 5x
Denhart's solution, 100 jg/ml denatured salmon sperm DNA,
0.1% SDS, 0.05 M phosphate buffer, pH 6.5, and 10% dextran
sulfate. After hybridization, blots were washed three times with
2X SSC and 0.1% SDS at room temperature, 10 minutes, and
twice more with 0.1>< SSC and 0.1% SDS at 50°C for 30 minutes.
Blots were then exposed to XAR-5 film (Kodak Laboratories,
Rochester, NY, USA) at —70°C overnight.
RNA analysis by reverse transcriptase (RT) polymerase chain
reaction (PCR) RNA extraction. Total RNA was extracted from
BDMØ as described for the Northern blot analysis. BDMØ in six
well plates were washed once with PBS and 1 ml of RNAzol°" B
was added to each well. The RNAzol'' B solution was then
transferred to eppendorf tubes, supplemented with 100 .d chlo-
roform followed by RNA extraction as described.
cDNA preparation. RNA samples were precipitated, dissolved in
12 d of water and heated to 65°C for 10 minutes. Each RNA
sample was supplemented with a reverse transcriptase reaction
mixture containing 1 il of Moloney murine leukemia virus-
reverse transcriptase (MMLV-RT; 200 U/1.d; Gibco BRL, Gaith-
ersburg, MD, USA), 4 1.d of 5x RT buffer (Gibco BRL), 0.5 p.!
DTT (0.1 M; Gibco BRL), 0.5 1.d RNase inhibitor (40 U/p.l;
Boehringer Mannheim), 1 p.1 oligo-d(T)12-18 mer (40 pmol/pl;
Boehringer Mannheim), and 1 p.! dNTP's (2.5 nmol/p.l each
nucleotide; Boehringer Mannheim). Tubes were incubated at
37°C for one hour, volumes were then adjusted to 60 p.1 by
addition of water, and the reverse transcriptase was inactivated by
a 10 minute incubation at 65°C.
PCR. Reverse transcribed samples of the cDNA preparation
were analyzed for TNFs and f3-actin specific cDNA by PCR
amplification. Specific primers (Table 1) were purchased from
Clontech (Palo Alto, CA, USA). Five microliters of reverse
transcribed RNA were incubated with 45 p.1 of PCR reaction
mixture containing 32.75 p.1 H20, 2.5 p.1 5' primer (20 p.M), 2.5 p.1
3' primer (20 p.M), 2 p.1 dNTP's (2.5 nmol/p.l each nucleotide), 5
p.! of 5 x reaction buffer (Perkin Elmer Cetus, ILS LTD, London,
UK) and 0.25 p.1 Taq polymerase (2.5 U, Amplitaq", Perkin
Elmer Cetus). cDNA was amplified in a temperature cycler as
9,
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Table 1. List of oligonucleotides used for RT-PCR DNA amplification
Gene Oligonucleotide sequence Product size References
TNFa 5' primer 5'-ATGAGCACTGAAAGCATGATCCGG-3' 695 bp [17]
3' primer 5'-GCAATGATCCCAAAGTAGACCTGCCC-3'
f3-actin 5' primer 5'-ATGGATGATGATATCGCCGCG-3' 1126 bp [181
3' primer 5'-CTAGAAGCATIT]TGCGGTGGACGATGGAGGGGCC-3'
Class Sequencea Source
AP-1' 5'-GATCCCTCGGGGTGAGTCATGGG
CTAG-3'
c-jun [20]
NF-KB 5'-gatccgAAAGAGGGAITFCACCTg-3' Human IL-2 [21]
Myc 5'-agcttCCCCACCACGTGGTGCCT
GActgca-3'
[22]
Small letters in DNA sequences are not part of the genomic sequences
and represent either Hind III/Pst I sites (Myc) or Barn HI sites (NF-KB).
Bold letters represent the consensus binding regions.
bThe AP-1 oligonucleotide contains a c-jun promoter sequence in
which cytosine and adenine residues were replaced by a guanine to
generate a consensus AP-1 site.
follows: 90 seconds at 94°C, five cycles of 45 seconds at 94°C, 1.30
minutes at 60°C and one minute at 72°C and 15 cycles where the
incubation at 72°C was prolonged by 8 seconds for each cycle.
Eight microliter samples of amplified cDNAs were resolved on
1.8% agarose gels and compared to "123 bp ladder" (Gibco BRL)
DNA size marker. Twenty PCR cycles were found in the expo-
nential phase of PCR amplification, thus allowing comparisons of
mRNA levels from different samples. Exponential amplification
of RT-PCR has been determined by repeated PCR at a wide
range of cycles and by choosing the optimal number of cycles
within the exponential amplification phase. Semiquantitative de-
termination of PCR products was performed using the UVP video
gel visualization system, and UVP GelBase Software (Ultra Violet
Product LTD, Cambridge, UK). The emission ratio of ethidium
bromide stained TNFa to !3-actin was calculated for each lane to
enable standardized comparisons of PCR products. To facilitate
comparison between different assays, the maximal emission ratio
value of each experiment was normalized to 100, and all other
samples values were normalized accordingly. Due to limitations of
the RT-PCR quantitation, only differences greater than fourfold
in at least three experiments, were considered significant.
Gel mobility shift assay
Nuclear and cytosolic extracts from P388D1 cells (4 X ioi
group) were prepared according to Osborn [19]. Protein concen-
tration was determined using a Bio-Rad protein assay (Bio-Rad
Laboratories, Munchen, Germany). Sequence of sense-strands of
synthetic oligonucleotides is listed in Table 2. Annealing of the
two strands of the corresponding oligonucleotide was performed
in 10 mM Tris-HC1, pH 8.0, and 10 mM MgCl2, starting at 70°C and
cooling at room temperature.
DNA binding of NF-KB was performed by a 25 minue incuba-
tion of the reaction mixture (in a total volume of 20 Ml) containing
3 to 10 .tg of nuclear or cytosolic extract in a binding buffer (10
mM Tris-HC1, pH 7.5, 50 mrvi NaCI, 1 mM EDTA and 5%
glycerol), 0.5 g poly dI-dT and 0.1 to 0.5 ng of [32P]-end labeled
oligonucleotide probes at room temperature. In the cytosolic
Fig. 1. Effect of CDS on LPS-induced TNFa mRNA. Blood-derived mac-
rophages (BDM0) were pretreated with CDS for various lengths of time,
as indicated, and then stimulated with LPS (10 jg/ml) for two hr in fresh
medium. RT-PCR of RNA samples of activated BDMØ were performed
(20 cycles). On each lane the TNFa product with the respective 13-actin
product as the control were loaded and analyzed on 1.8% agarose gel.
Results demonstrate the negative picture of ethidium bromide-stained
amplified DNA bands. M designates the 123 bp molecular weight standard
from Gibco-BRL. Three additional preparations from different donors
were studied and yielded similar results (emission TNFa//3-actin ratio data
of all 4 experiments are summarized in Fig. 2).
reaction, 0.2% sodium deoxycholate was added. DNA binding
reactions of AP-1 and Myc were performed in a slightly modified
buffer containing 50 mrvi Tris-HC1, pH 7.5, 100 mrvi DTT, 1 mM
EDTA, 2% glycerol, 0.1% NP-40, 0.5 g poly dI-dT and 0.1 to 0.5
ng of [32PJ-end labeled oligonucleotide probes.
Samples were resolved by electrophoresis on 4% polyacryl-
amide gels in Tris-borate buffer (22.5 mrvt Tris-borate and 0.5 mM
EDTA) for three hours at room temperature at 150 volts. Gels
were then dried and autoradiographed overnight with intensifying
screen using Kodak XAR-5 film at —70°C. Protein-DNA binding
specificity, was tested by competition with "cold" oligonucleotides
as described [23].
Results
Effect of CDS on TNFa gene transcnption
Previous results have demonstrated that CDS inhibits TNFa
secretion and synthesis) by LPS activated Mø [5, 7, 24]. To test
whether LPS inhibits TNFa synthesis at the transcriptional or
post-transcriptional level, we treated BDMØ with CDS and then
stimulated them with LPS followed by RT-PCR analysis of the
TNFa mRNA levels.
The results (Figs. 1 and 2) demonstrated a rapid and time-
dependent lowering of the LPS-induced TNFa mRNA levels by
CDS; 15 minutes of CDS pretreatment of BDMØ resulted in an
Table 2. List of oligonucleotides used for binding studies
— + + ÷ + + LPS
M — — 5 10 15 30 CDS (mm)
—3-actin
—TNFa
bp
1107
984
861
738
615
492
369
246
123
I.
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Fig. 2. Densitometty of the effect of CDS on LPS-induced TNFa mRNA.
BDMØ were pretreated with CDS for various time periods, as indicated,
and then stimulated with LPS (10 j.tg/ml) for two hours in fresh medium.
RT-PCR products of experiments described in Fig. 1 were separated on
ethidium bromide agarose gels. The ethidium bromide emission intensity
of the bands were evaluated using UVP GDS 5000 video system and
software (UVP Inc.,). The maximal emission ratio of each experiment was
normalized to 100 and all the other samples were adjusted accordingly
allowing comparison between the experiments. Results are presented as
mean standard deviation (SD) of experiments performed on four
different donors.
almost complete suppression of TNFa mRNA. Inhibition was not
due to some non-specific toxicity of the CDS, because transcrip-
tion of the /3-actin gene in the same mRNA samples was not
affected by CDS, even after longer incubation periods. In addi-
tion, LDH release and trypan blue dye exclusion tests indicated
that CDS was not toxic to the cells and over 80% were viable when
treated with CDS for 30 minutes (not shown).
To confirm the findings using an additional cell system, we used
the murine MØ-like cell line, P388D1, which is considered to be
a good model for resident and exudate macrophages [25]. In a
preliminary study we found that TNF production by P388D1 cells
and the inhibition of TNF secretion by CDS were similar to our
findings on PMØ and BDMØ (data not shown). CDS pretreat-
ment of P388D1 cells followed by LPS stimulation and Northern
blot analysis revealed that 15 minutes of CDS pretreatment
induced a near complete suppression of TNFa mRNA expression
(Fig. 3). Furthermore, CDS reduced the basal level of TNFs
mRNA observed in resting cells.
Lactate and acidity of the CDS mediate the inhibitory effect on
TNFx gene transcription
To determine the CDS constituents that affect TNFa mRNA
expression, we pretreated BDMØ with CDS preadjusted to
various pH levels, or with CDS depleted of glucose and/or lactate,
as indicated in Table 1. Cells were then stimulated with LPS for
two hours and TNFa mRNA levels were determined by RT-PCR.
Although marked inhibition was seen after only 15 minutes of
preincubation, to enhance the sensitivity of detecting inhibitory
constituents of CDS the period was increased to 45 minutes in this
phase. Results (Fig. 4) showed that CDS at its original pH of 5.2
suppressed TNFc mRNA levels. By contrast, CDS preadjusted to
close to neutral pH (pH 6.0 to 7.4) had no inhibitory effect on
TNFa. Furthermore, removal of the lactate from the CDS,
without modifying the original pH, reversed its inhibitory effect
(Fig. 5). Replacement of glucose by manitol or changing the
osmolarity of CDS by reducing the glucose concentration from
Fig. 3. Effect of CDS on LPS-induced TNFx mRNA in P388D1 cells.
P388D1 macrophage-like cells were pretreated with CDS for various
periods of time, as indicated, and then stimulated with LPS (10 Wml; 2
hr) in fresh medium. Total RNA was prepared from cells and 15 g from
each sample was size fractionated in 1.4% agarose 0.66 M formaldehyde
gel followed by blotting onto nylon membrane and hybridization with
random-primed [32P]-labeled TNFa or 13-actin specific DNA probes.
Radioactive bands were visualized by 1 day autoradiography at —70°C.
Hybridization was performed sequentially on the same membrane. Data
demonstrated are representative of one out of three experiments
performed.
1.5% (346 MOsm) to 0.2% (241.5 MOsm) were ineffective in
abolishing the CDS inhibitory effect on TNFa mRNA expression
(Fig. 5).
These findings were further supported from analyses of P388D1
cells under similar assay conditions and determination of TNFa
mRNA levels by Northern blotting (Fig. 6). Thus, removal of
lactate from the CDS abolished its inhibitory effect on TNFs
mRNA expression while replacement of glucose by manitol or
reduction of glucose concentration had no effect on the CDS-
induced inhibition of TNFa mRNA levels.
CDS inhibits DNA binding activity of NF-KB
The promoter region of TNFa gene possesses several nude-
otide sequence motifs that may function as recognition elements
for the NF-RB transcription regulator [9]. Furthermore, NF-KB-
type proteins and enhancer regions were shown to be involved in
LPS-mediated transcriptional activation of the TNFa gene in Mø
[10]. It is possible, therefore, that CDS mediates its inhibitory
effect on TNFa gene transcription by directly modulating the
activity of NF-KB.
To test this hypothesis we used P388D1 cells and measured the
effect of CDS on LPS-mediated induction of NF-KB DNA binding
activity using a gel mobility shift assay. Nuclear and cytosolic
extracts of cells were incubated with double stranded oligonucle-
otide possessing the NF-KB consensus site, and the presence of
—
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Fig. 4. The inhibitoiy effect of CDS is dependent on its acidic pH level.
BDMØ were pretreated with commercial dialysis solutions that were
preadjusted to various pH levels for 45 mm, and then stimulated with LPS
(10 gIml) for 2 hr. Levels of TNFa and /3-actin mRNA were determined
by RT-PCR and agarose gel electrophoresis. These data represent results
similar to those obtained in experiments performed on BDMØ from 3
different donors.
246
123
Fig. 5. Effect of individual constituents of the CDS on its capacity to inhibit
TNFa mRNA expression in BDMØ. BDMØ were pretreated for 45 mm
with modified CDS as indicated; unmodified CDS (CDS), CDS with no
lactate (-L), CDS with no glucose (-G), CDS depleted of both lactate and
glucose (-G -L), CDS solution containing reduced glucose concentration
(0.2% G) and medium. Detailed composition of the various solutions is
shown in Table 3. After LPS stimulation for 2 hr, TNFa and p-actin
mRNA levels were tested by RT—PCR.
bound proteins was determined by testing their ability to induce a
retarded mobility of the DNA on polyacrylamide gels.
It should be indicated that NF-KB complexes, like a variety of
other transcription factors, are formed by homo- or hetero-
dimerization of structurally related proteins. The NF.xB is found
as an active heterodimeric transcription factor composed of 50
kDa and 65 kDa proteins and as a nonactive homodimer of 50
kDa proteins. Although both complexes exhibit DNA binding
activity in a gel mobility shift assay, only the upper of the two
Fig. 6. Effect of individual constituents of the CDS on TNFa mRNA
expression in P388D1 cells. P388D1 cells were pretreated with modified
CDS as indicated; complete CDS (CDS), CDS with no lactate (-L), CDS
with no glucose (-G), CDS depleted of both lactate and glucose (-G -L),
CDS solution containing reduced glucose concentration (0.2% G) and
medium. Detailed composition of the various solutions is shown in Table
3. After LPS stimulation total RNA was prepared from the cells and
TNFa and 13-actin mRNA levels were tested by Northern blotting as
described in the legend to Fig. 3.
Nuclear extracts from LPS-stimulated P388D1 cells, but not
from unstimulated cells, exhibited DNA binding activity to the
NF-KB site containing oligonucleotide (Fig. 7), and could be
competed out by 100-fold excess of specific unlabeled "cold"
DNA probe. This activity was similar to that obtained by TPA +
ionomycin stimulation of the EL-4 leukemic T cells, as reported
earlier [23, 26]. Fifteen minutes of pretreatment of cells with CDS
resulted in complete eradication of the NF-KB DNA binding
activity observed after LPS stimulation (Fig. 7).
To test whether CDS functions as a general inhibitor of DNA
binding activity of transcription factors, we examined its effect on
two addjtional ubiquitous transcription factors, Myc and AP-1,
that regulate transcription of various early activation genes.
Analysis of nuclear abstracts from LPS-stimulated P388D1 cells
demonstrated that, in contrast to its inhibitory effect on NF-KB,
CDS does not affect DNA binding activity of AP-1 (Fig. 8).
Similar results were obtained when Myc was tested (not shown).
We next tested the correlation between the CDS inhibitory
effects on TNFa gene transcription and NF-KB DNA binding
activity with respect to the different constituents of CDS. In
complete agreement with the results obtained with TNFa induc-
tion, only the original acidic CDS (pH 5.2) inhibited NF-KB DNA
binding activity of nuclear proteins from LPS stimulated cells,
while CDS preadjusted to higher pH levels (pH 6.0 to 7.0) was not
inhibitory (Fig. 9). Furthermore, removal of lactate (-Lac), but not
CDS(pH) -)M 52 6.0 6.5 7.0 7.4 coO ..aO0 I I -0I G)o
bp
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Table 3. Constituent of CDS and modified CDS solution
Component CDS
CDS without
lactate
(-L)
CDS without
glucose
(-G)
CDS without
lactate and glucose
(-L -G)
CDS with low osm.
0.2% glucose
(0.2%G)
Na mM 100 140 100 140 100
Mg mM 0.75 0.75 0.75 0.75 0.75
Ca mM 1.75 1.75 1.75 1.75 1.75
Cl miv 100.75 100.75 100.75 100.75 10175
Lactate m 40 — 40 — 40
Glucose % 1.5 1.5 — — 0.2
Manitol % — — 1.5 1.5 —
pH 5.2 5.2 5.2 5.2 5.2
Osmolarity mOsm 346 346 346 346 241.5
+
CT CDS lOOx
(15) coldLPS — + — + +
Fig. 7. Effect of CDS on LPS-induced NF- KB DNA binding activity.
Non-treated control (CT) or CDS-treated P388D1 cells were incubated in
medium or stimulated with LPS. Nuclear lysates (10 g protein/lane) were
incubated with [32P]-end-labeled dsDNA oligonucleotide possessing the
NF-KB consensus sequence, and the ability of bound proteins to induce
retarded mobility of the radiolabeled probe on polyacrylamide gels was
tested. Binding specificity was tested using X 100 excess of "cold" DNA
probe and the same nuclear proteins from activated cells. Radioactive
bands were visualized by 1 day autoradiogrpahy at —70°C.
glucose (-Glu), from the CDS eliminated its inhibitory effect on
NF-KB DNA binding activity (Fig. 10).
NF-KB is found in the cytosol of resting cells in a non-active
form, and only upon cell activation does it become active and
translocate to the nucleus. We confirmed these findings (Fig. lOB)
by demonstrating that cytosolic proteins from resting P388D1
cells did not exhibit NF-KB DNA binding activity. LPS stimulation
dramatically increased the NF-KB binding activity of cytosolic
proteins while 15 minute preincubation of cells with CDS com-
pletely blocked the effect of LPS (Fig. lOB).
To test the direct effects of CDS on TNFa RNA stability, LPS
stimulated cells were incubated for 15 minutes with CDS and then
treated with the transcription inhibitor actinomycin D. As shown
in Figures 11 and 12, no differences were found in TNFa mRNA
stability when comparing the results of cells treated or untreated
Fig. 8. Effect of CDS on LPS-induced AP-1 DNA binding activity. Non-
treated control (CT) or 30 mm CDS-treated P388D1 cells were incubated
in medium or stimulated with LPS as indicated. For the AP-1 assay,
nuclear lysates were incubated with [32P}-end-labeled dsDNA oligonucle-
otide possessing the AP-1 consensus sequence, and ability of bound
proteins to induce retarded mobility of the radiolabeled probe on poly-
acrylamide gels was tested.
by CDS (same half life of approximately 1 hr). Thus, there is no
evidence for supporting direct effects of CDS on TNFa mRNA
stability.
Discussion
Cytokines are important mediators of the immune system in
general, and macrophage inflammatory responses in particular, as
they trigger a cascade of events leading to inflammatory responses
that coincide with massive polymorphonuclear cells (PMN) infil-
tration. Patients treated by peritoneal dialysis have been shown to
suffer from a high incidence of peritoneal infections, which are
associated with reduced local activity of Mø functions [3]. The
purpose of this study was to elucidate the mechanism involved in
CDS-induced suppression of TNFa release from Mø. We found
that CDS decreases the level of TNFs mRNA in LPS-activated
macrophages. Time course studies were performed on both
BDMØ and P388D1 cells, TNFa mRNA levels were tested by
RT-PCR or by Northern blot, respectively. Results demonstrated
p50
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Fig. 9. Inhibition of NF-kB DNA binding activity by CDS is dependent on its
low pH. Non-treated control (CT) and P388D1 cells that were pretreated
for 15 mm with CDS preadjusted to different pH levels, as indicated, were
stimulated with LPS (10 rgIml) for 1 hr. Nuclear lysates were prepared
and protein binding to [32P]-labeled dsDNA oligonucleotides possessing
the NF-KB consensus sequence was tested using the gel mobility shift assay
as described in Fig. 7.
Fig. 10. Effect of individual constituents of the CDS on its capacity to inhibit
NF-gB DNA binding activity and CDS inhibition of NF-,eB formation in the
cytosol. Non-treated control (CT) and P388D1 cells that were pretreated
for 15 mm with unmodified or modified CDS solutions without glucose
(-Glu) or without lactate (-Lac) were stimulated with LPS as indicated.
NF-KB DNA binding activity of nuclear or cytosolic lysates was performed
as described in the legend to Fig. 7.
that CDS induced a rapid decrease of TNFa mRNA levels within
15 minutes of exposure to the CDS. Two factors contributed to
the inhibitory effect of CDS: the low pH and the lactate content.
Raising the CDS pH levels above 6.0 or removal of the lactate
completely abolished its depletive effect on TNFa mRNA levels.
Fig. 11. The effect of CDS on TNFa mRNA stability. BDMØ were
stimulated for 2 hr with LPS (10 j.Lg/ml), exposed for 15 mm to medium
(Control) or CDS, and then replaced with fresh medium and incubated for
an additional 30 mm; subsequently actinomycin D was added (1 g/ml)
and the cells were incubated for various lengths of time followed by RNA
extraction. TNFa mRNA levels in control or CDS treated cells were tested
by RT-PCR. "Time" indicates the duration of exposure to actinomycin D.
Two additional preparations from different donors were studied and
yielded similar results (emission densitometry of TNFo RT-PCR data of
all 3 experiments are summarized in Fig. 12).
These two factors acted in a complementary fashion, since neither
alone was sufficient for decreasing TNFa mRNA levels.
Previous results [5, 24] have demonstrated that the inhibitory
effect of CDS is mainly due to its high osmolarity (346 mOsm).
However, we could not confirm these data. Furthermore, we
found that glucose replacement with manitol (maintaining con-
stant osmolarity of 346 mOsm) or reducing the glucose concen-
tration (from 346 to 241 mOsm) did not eliminate the inhibitory
effect of CDS. This disagreement about the effect of osmolarity on
TNFa, could be due to the different assay systems, as well as to the
longer incubation times and the use of solution containing glucose
concentration higher then 1.5%. The experimental conditions, the
time course, as well as the effects of the CDS constituents on
TNFa release from PMØ in a previous study [7] were similar to
those of the present study. Thus, we assume that the CDS affects
TNFa release primarily through decreasing the levels of mRNA.
This could reflect either decreased TNFa gene transcription or
increased TNFa mRNA catabolism. Since in the actinomycin D
experiments, no differences were found in the rate of degradation
of TNFa RNA between CDS treated and untreated cells, it can be
concluded that the rate of catabolism of this cytokine is not
affected by CDS.
Previous studies have shown that interaction of the NF-KB with
the TNFa promoter is required for an efficient LPS-mediated
transcriptional activation of the TNFts gene [9—11]. The NF-KB
transcription factor is found in the cytosol of resting cells in an
inactive form bound to an inhibitor molecule, 1KB, that prevents
NF-KB from translocating into the nucleus and binding to DNA.
Cell activation with a variety of exogenous stimuli resulted in
NF-KB/IKB dissociation and translocation of the active NF-KB
complex into the nucleus where it induces transcription.
To investigate possible effects of CDS on transcription factors
involved in the regulation of TNFs gene transcription, we studied
the pattern of NF-KB activity in nuclear extracts from non-treated
or CDS-treated macrophages stimulated with LPS. We found that
CDS inhibited NF-KB DNA binding activity similar to its inhibi-
tory effect on TNFa gene transcription. Thus a 15 minute
exposure of P388D1 cells to CDS completely abolished the NF-KB
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Fig. 12. Densitomet,y of the effect of CDS on TNFa mRNA stability. As
described in the legend to Fig. 11, LPS stimulated BDMØ were exposed
for 15 mm to (A) medium (Control) or (B) CDS, and after 30 mm of
resting in fresh medium, actinomycin D was added for various lengths of
time as indicated. TNFa mRNA levels in control or CDS treated cells
were tested by RT-PCR. The ethidium bromide emission intensity of the
bands was evaluated using UVP GDS 5000 video system and software
(UVP Inc.,). The maximal emission ratio of each experiment was normal-
ized to 100 and all the other samples were adjusted accordingly thus
allowing comparison between the experiments. Results are presented as
mean SD of experiments from 3 different donors.
responses, such as the IL-2, IL-6, granulocytes-macrophage col-
ony stimulating factor (GM-CSF), granulocytes CSF (G-CSF),
IL-2 receptor, T cell antigen receptor 13 chain and major histo-
compatibility complex (MHC) class I [8]. Partial or complete
suppression of these genes may have profound effects on the
inflammatory response and on other immune responses in the
peritoneum, and should be considered when testing the effects of
the CDS on the peritoneal environment.
The mechanism whereby the CDS's low pH and high lactate
concentration inhibit NF-KB activity and reduces TNFa mRNA
levels still remains unclear. Recent data [27—29] demonstrated
that exposure of phagocytic cells to CDS is followed by a profound
decline in the cytoplasmic pH. Since the maintenance of a
near-normal cytoplasmic pH is vital for normal cell function, it is
tempting to speculate that the cellular acidification caused by the
combination of low pH and lactate is the main reason for blocking
NF-xB DNA binding activity and production of TNFa.
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